Vaccination Status, Knowledge and Attitude in Korean Patients With IBD
NCT01984879 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 287
Last updated 2022-12-28
Summary
The purpose of this study is to investigate the vaccination status, knowledge about vaccination, and attitude to vaccination of the Korean patients with inflammatory bowel diseases
Conditions
Interventions
- OTHER
-
Survey with structured questionnaire form for inflammatory bowel disease patient group
For patients with inflammatory bowel disease, survey with structured questionnaire form is carried out.
Sponsors & Collaborators
-
Asan Medical Center
lead OTHER
Principal Investigators
-
Byong Duk Ye, MD, PhD · Asan Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-11-30
- Primary Completion
- 2015-12-31
- Completion
- 2016-03-31
Countries
- South Korea
Study Locations
More Related Trials
-
Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea
NCT02229344 ·Status: COMPLETED
-
Metagenomic Analysis of Gut Microbiome in Korean Patients With Ulcerative Colitis
NCT01010815 ·Status: UNKNOWN
-
Clinical Course of Korean Crohn's Disease Cohort
NCT01554007 ·Status: UNKNOWN
-
Microbiome and Genetic Analysis of Familial IBD
NCT03515070 ·Status: COMPLETED
-
Sick Leave, Work Disability and Quality of Life in Korean Patients With Inflammatory Bowel Diseases
NCT03565432 ·Status: COMPLETED
-
Efficacy Safety Study of Flu Vaccine in Immunodepression Patients
NCT01022749 ·Status: COMPLETED ·Phase: PHASE3
-
The Comparison Between the Biomarkers in Inflammatory Bowel Disease Patients and General Control Group
NCT03778918 ·Status: UNKNOWN
-
Fecal Microbiota Transplantation and Analysis of Fecal Microbiome in IBD Patients
NCT03399188 ·Status: UNKNOWN ·Phase: NA
-
SNU IBD Cohort Study : Searching for Characterization of High Risk Populations for Developing Inflammatory Bowel Disease
NCT07011979 ·Status: RECRUITING
-
A Prospective, Mono-Country and Multi-center Study to Observe Safety and Effectiveness of Adalimumab in KoREan Intestinal Behcet's Disease(BD) Patients
NCT02687828 ·Status: COMPLETED
-
Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea.
NCT01731665 ·Status: RECRUITING
-
A Multicenter Clinical Trial: Efficacy, Safety of Fecal Microbiota Transplantation for Inflammatory Bowel Disease
NCT04521205 ·Status: RECRUITING ·Phase: PHASE1
-
Efficacy and Safety of Vedolizumab in Biologic-naïve Korean Patients With Moderate to Severe Inflammatory Bowel Disease
NCT04919252 ·Status: UNKNOWN ·Phase: PHASE3
-
Covid-19 Vaccine Responses in Patients With Inflammatory Bowel Diseases
NCT05067959 ·Status: UNKNOWN
-
Efficacy Study of Pneumococcal Vaccination in Crohn's Disease
NCT01505855 ·Status: COMPLETED ·Phase: PHASE4
-
Diagnostic Validity of [18F]FSPG PET for the Assessment of Disease Activity in Inflammatory Bowel Disease
NCT03546868 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Physical Activity on Patients With Inflammatory Bowel Disease
NCT02222584 ·Status: COMPLETED
-
Assessment of the Response to the Complete Vaccination Guidelines Against Sars-cov2
NCT05153850 ·Status: UNKNOWN
-
Prediction Model for Response to Biologics and Small Molecular Agent for UC
NCT05186623 ·Status: RECRUITING
-
Determining the Relationship Between Gut Microbiota and Immune Response to Influenza or COVID-19 Vaccine
NCT05584735 ·Status: COMPLETED
-
Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease
NCT05014555 ·Status: UNKNOWN
-
Omics-driven Research on the Gut-Oral Microbiome, Metabolome, Lifestyle, and Clinical Integration in Korean Inflammatory Bowel Disease
NCT06124833 ·Status: RECRUITING
-
Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD)
NCT01346826 ·Status: COMPLETED ·Phase: PHASE4
-
Interactions Between Immune Cells of Intestinal Mucosa or Peripheral Blood With the Extracellular Matrix in Inflammatory Bowel Disease (IBD)
NCT00915044 ·Status: UNKNOWN
-
Post Marketing Surveillance of Remicade
NCT00724529 ·Status: COMPLETED